- Home
- ORI vs MDGL Comparison
ORI vs MDGL Comparison
Compare ORI & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- MDGL
- Stock Information
- Founded
- ORI 1923
- MDGL 2011
- Country
- ORI United States
- MDGL United States
- Employees
- ORI N/A
- MDGL N/A
- Industry
- ORI Property-Casualty Insurers
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- ORI Finance
- MDGL Health Care
- Exchange
- ORI Nasdaq
- MDGL Nasdaq
- Market Cap
- ORI 10.8B
- MDGL 9.6B
- IPO Year
- ORI N/A
- MDGL N/A
- Fundamental
- Price
- ORI $46.56
- MDGL $603.99
- Analyst Decision
- ORI Strong Buy
- MDGL Strong Buy
- Analyst Count
- ORI 2
- MDGL 13
- Target Price
- ORI $46.50
- MDGL $543.33
- AVG Volume (30 Days)
- ORI 2.0M
- MDGL 452.1K
- Earning Date
- ORI 10-23-2025
- MDGL 11-04-2025
- Dividend Yield
- ORI 2.50%
- MDGL N/A
- EPS Growth
- ORI N/A
- MDGL N/A
- EPS
- ORI 3.32
- MDGL N/A
- Revenue
- ORI $8,748,900,000.00
- MDGL $740,640,000.00
- Revenue This Year
- ORI $10.22
- MDGL $395.75
- Revenue Next Year
- ORI $6.10
- MDGL $65.73
- P/E Ratio
- ORI $13.99
- MDGL N/A
- Revenue Growth
- ORI 7.08
- MDGL 864.21
- 52 Week Low
- ORI $33.00
- MDGL $265.00
- 52 Week High
- ORI $46.63
- MDGL $604.81
- Technical
- Relative Strength Index (RSI)
- ORI 72.90
- MDGL 77.14
- Support Level
- ORI $40.61
- MDGL $535.00
- Resistance Level
- ORI $46.35
- MDGL $594.99
- Average True Range (ATR)
- ORI 0.87
- MDGL 28.70
- MACD
- ORI 0.42
- MDGL 7.02
- Stochastic Oscillator
- ORI 98.51
- MDGL 99.09
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.